Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury

Annals of Plastic Surgery

Volumn 61, Issue 3, 2008, Pages 330-336

  Lin, Jeng Yee ^a,b   Hung, Li Man ^b   Lai, Lingo Yiling ^c   Wei, Fu Chan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ICAM 1; Ischemia reperfusion; Kappa opioid receptor; Microcirculation; Selectin

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; CREATINE KINASE ISOENZYME; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; NORBINALTORPHIMINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; CAPILLARY DENSITY; CELL SWELLING; CONTROLLED STUDY; CREMASTER MUSCLE; DRUG EFFECT; DRUG MECHANISM; LEUKOCYTE ADHERENCE; MALE; MICROCIRCULATION; MICROSCOPY; MUSCLE FLAP; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VENULE; ANIMAL; CELL ADHESION; DRUG ANTAGONISM; ISCHEMIA; LEUKOCYTE; METABOLISM; PLASTIC SURGERY; RANDOMIZATION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CELL ADHESION; ENDOTHELIUM, VASCULAR; INTERCELLULAR ADHESION MOLECULE-1; ISCHEMIA; LEUKOCYTES; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; REPERFUSION INJURY; SURGICAL FLAPS;

EID: 53149095454     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31815b9e64     Document Type: Article

References (28)

1. Calhoun KH, Tan L, Seikaly H. An integrated theory of the no-reflow phenomenon and the beneficial effect of vascular washout on no-reflow. Laryngoscope. 1999;109:528-535.
2. Allen DM, Long-en C, Seaber AV, Urbaniak JR. Pathophysiology and related studies of the no reflow phenomenon in skeletal muscle. Clin Orthop Relat Res. 1995;314:122-133.
3. Manson PN, Anthenelli RM, Im MJ, et al. The role of oxygen free radicals in ischemic tissue injury in island skin flaps. Ann Surg. 1984; 198:87-90.
4. May JW, Chait LA, O'Brien BM, Hurley JV. The no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg. 1978;61:256-267.
5. Korthuis RJ, Granger DN, Tonnsley MI, Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res. 1985;57:599-609.
6. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
7. Rothelin R. Overview of leukocyte adhesion. Neurology. 1997;49: S3-S4.
8. Somers WS, Tang J, Shaw GD, et al. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P-and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103:467-479.
9. McEver RP. Selectin: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemost. 1991;65:223-228.
10. Cartwright JE, Whitley GJ, Johnstone AP. The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp Cell Res. 1995;217:329.
11. Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol. 1993;71:76-81.
12. Wang WZ, Anderson G, Firrell JC, et al. Ischemia preconditioning versus intermittent reperfusion to improve blood flow to a vascular isolated skeletal muscle flap of rats. J Trauma. 1998;45:953-959.
13. Adanali G, Ozer K, Siemionow M. Early and late effects of ischemic preconditioning on microcirculation of skeletal muscle flaps. Plast Reconstr Surg. 2001;109:1344-1351.
14. Hung LM, Wei W, Hsueh YJ, et al. Ischemia preconditioning ameliorates microcirculatory disturbance through downregulation of TNF-alpha production in a rat cremaster muscle model. J Biomed Sci. 2004;11:773-780.
15. Coles JA Jr, Sigg DC, Iaizzo PA. Role of κ-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol. 2002;284:H2091-H2099.
16. Wang GY, Wu S, Pei JM, et al. κ-but notδ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol. 2001;280:H3841-H391.
17. Chen TY, Goyagi T, Toung TJ, et al. Prolonged opportunity for ischemic neuroprotection with selective κ-opioid receptor agonist in rats. Stroke. 2004;35:1180-1185.
18. Wong TM, Wu S. Role of kappa opioid receptor in cardioprotection of preconditioning: implications in cardiac surgery. J Card Surg. 2002; 462-464.
19. Liu H, Zhang HY, Zhu X, et al. Preconditioning blocks cardiocyte apoptos: role of K (ATP) channels and PKC-epsilon. Am J Physiol Heart Circ Physiol. 2002;282:H1380-H1386.
20. Zhou JJ, Pei JY, Wang GY, et al. Inducible HS70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 2001;281:40-47.
21. Xia Q, Zhang WM, Shen YL, et al. Decreased affinity of κ-receptor binding during reperfusion following ischemic preconditioning in the rat heart. Life Sci. 1996;58:1307-1313.
22. Wilson J, Walker JS, Antoon JS, et al. Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: inhibition by κ-opioid agonist but not by NSAID. J Rheuma. 1998;25:3499-505.
23. Belkowski SM, Alicea C, Eisenstein TK, et al. Inhibition of interleu-kin-1 and tumor necrosis factor-α, synthesis following treatment of macrophages with the kappa opioid agonist U-50488H. J Pharmacol Exp Ther. 1995;273:1491-1496.
24. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res. 1973;5:384-394.
25. Wang GY, Zhou JJ, Wong TM, et al. Protein kinase C-εis a trigger of delayed cradioprotection against myocardial ischemia of κ-opioid receptor stimulation in rat ventricular myocytes. J Pharmacol Exp Ther. 2001;299:603-610.
26. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte, involvement of κ-opioid receptor. Cir Res. 1999;84:1388-1395.
27. Cao Z, Liu L, Winkle DMV. Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ. 2003;10:H1032-H1039.
28. Osada M, Netticadan T, Kawabata K, et al. Ischemia preconditioning prevents I/R induced alterations in SR calcium-camodulin protein kinase II. Am J Physiol. 2000;278:H1791-1798.